EDGAR Filing Documents for 0001193125-05-107256

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-05-107256

Filing Date

2005-05-13

Accepted

2005-05-13 16:14:46

Documents

Period of Report

2005-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q FOR CORTEX PHARMACEUTICALS, INC.	d10q.htm	10-Q	201271
2	CEO CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A)	dex311.htm	EX-31.1	10001
3	CFO CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A)	dex312.htm	EX-31.2	9837
4	CEO & CFO CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350	dex32.htm	EX-32	5584
	Complete submission text file	0001193125-05-107256.txt		228081

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718

Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)